Myeloproliferative Neoplasms News

Justin Taylor, MD, of Memorial Sloan Kettering Cancer Center and Roger Belizaire, MD, PhD, of Brigham and Women’s Hospital have been chosen to participate in the ASH–Harold Amos Medical Faculty Development Program.

ASH presented 2017 Scholar Awards to more than two dozen fellows and junior faculty who are dedicated to careers in hematology research.

Most patients with cancer reported decreased levels of physical activity 1 year after diagnosis, according to a cross-sectional study scheduled for presentation at the Cancer Survivorship Symposium.

Cancer mortality in the United States decreased by more than 20% from 1980 to 2014, according to a study conducted by researchers from University of Washington and published in JAMA.

The investigational hallucinogenic drug psilocybin reduced clinician- and patient-reported depression, anxiety and mortality-associated anxiety among adults with cancer, according to results of a small double blind study.

Fewer than half of childhood cancer survivors receive recommended long-term follow-up care, according to findings of a study led by researchers at Roswell Park Cancer Institute.

The implementation of a simple technology to collect and store patient-reported outcomes could improve patients’ quality of life and outcomes and enhance patient–provider communication, according to Ethan Basch, MD, MSc, director of UNC Lineberger Cancer Outcomes Research program.

The American Academy for Cancer Research released the first set of cancer genomic data from Project GENIE, a multiphase, international data-sharing effort.

The ASH Annual Meeting and Exposition featured the latest breakthroughs in treatment — including advances in immunotherapy and gene therapy — as well as advances in prevention and diagnosis of benign and malignant hematologic conditions.

A steady decline in smoking and advances in early detection and treatment have contributed to a 25% reduction in cancer death rates in the United States since 1991, according to Cancer Statistics 2017, the American Cancer Society’s comprehensive annual report on cancer incidence, mortality and survival.